Ditropan and Sinus bradycardia - a phase IV clinical study of FDA data

Summary:

Sinus bradycardia is reported as a side effect among people who take Ditropan (oxybutynin chloride), especially for people who are female, 50-59 old, also take Celebrex, and have Bone density abnormal.

The phase IV clinical study analyzes which people have Sinus bradycardia when taking Ditropan. It is created by eHealthMe based on reports of 11,571 people who have side effects when taking Ditropan from the FDA, and is updated regularly.

What is Ditropan?

Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.

What is Sinus bradycardia?

Sinus bradycardia (an unusually slow heartbeat due to heart disease) is found to be associated with 904 drugs and 1,053 conditions by eHealthMe. Check the latest studies of Sinus bradycardia.

On Jul, 09, 2026

11,571 people reported to have side effects when taking Ditropan.
Among them, 30 people (0.26%) have Sinus bradycardia.

Among these 30 people:

What is the gender of people who have Sinus bradycardia when taking Ditropan? *

female: 82.76 %
male: 17.24 %

What is the age of people who have Sinus bradycardia when taking Ditropan? *

What are other drugs people take besides Ditropan? *

What are other side effects people have besides Sinus bradycardia? *

Acute Kidney Failure: 15 people, 50.00%
Drowsiness: 14 people, 46.67%
Fall: 14 people, 46.67%
Gait Disturbance: 13 people, 43.33%
Pain: 13 people, 43.33%
Depression: 13 people, 43.33%
Stress And Anxiety: 12 people, 40.00%
Nausea (feeling of having an urge to vomit): 12 people, 40.00%
Osteonecrosis Of Jaw (death of bone of jaw): 12 people, 40.00%
Osteopenia (a condition where bone mineral density is lower than normal): 12 people, 40.00%

What are the existing conditions these people have? *

Bone Density Abnormal: 10 people, 33.33%
Osteoporosis (bones weak and more likely to break): 4 people, 13.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 13.33%
Pain: 3 people, 10.00%
Iron Deficiency Anaemia: 3 people, 10.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 10.00%
Prostate Cancer: 2 people, 6.67%
High Blood Cholesterol: 2 people, 6.67%
Diabetic Gastroparesis (paralysis of the muscles of the stomach caused by diabetes): 2 people, 6.67%
Urinary Tract Infection: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ditropan and have Sinus bradycardia?

- Check whether Sinus bradycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ditropan:

Ditropan (11,799 reports)

Browse all side effects of Ditropan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinus bradycardia:

Sinus bradycardia (904 drugs)

Browse all the conditions that are associated with Sinus bradycardia:

Sinus bradycardia (1,053 conditions)

Related publications that referenced our studies

Yaylaci S, Kocayigit I, Genc A, Tamer A, Gunduz H, "Sinus bradycardia caused by flurbiprofen intoxication", Nigerian Journal of Cardiology, 2015 Jan .
Yaylaci S, Kocayigit I, Genc A, Tamer A, Gunduz H, "Sinus bradycardia caused by flurbiprofen intoxication", Nigerian Journal of Cardiology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on oxybutynin chloride (the active ingredients of Ditropan) and Ditropan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.